Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-10

Clinical Trial Update: Yoga-based, Movement Therapy Device as Noninvasive Glymphatic Clearance Augmentation in Alzheimer's Disease. [NA]

View source ↗

Summary

This clinical trial evaluates a yoga-based movement therapy device intended to noninvasively augment glymphatic clearance in Alzheimer's disease; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: CIATRIX, INC. | Conditions: Alzheimer Disease, Mild Cognitive Impairment (MCI) | NA | Status: NOT_YET_RECRUITING